Sarcoidosis following COVID infection: A case series

David J F Smith; Jamilah Meghji; Mufaddal Moonim; Clare Ross; Patrizia Viola; Melissa Wickremasinghe; Laura E Gleeson

doi:10.1002/rcr2.1231

Sarcoidosis following COVID infection: A case series

Respirol Case Rep. 2023 Oct 13;11(11):e01231. doi: 10.1002/rcr2.1231. eCollection 2023 Nov.

Authors

David J F Smith^{1

2}, Jamilah Meghji³, Mufaddal Moonim^{2

4}, Clare Ross², Patrizia Viola^{2

4}, Melissa Wickremasinghe², Laura E Gleeson^{2

5}

Affiliations

¹ Department of Inflammation Repair & Development, National Heart & Lung Institute Imperial College London London UK.
² Department of Respiratory Medicine St Mary's Hospital, Imperial College Healthcare NHS Trust London UK.
³ Department of Respiratory Medicine Cambridge University Hospitals NHS Trust Cambridge UK.
⁴ North West London Pathology London UK.
⁵ Department of Respiratory Medicine Trinity College Dublin Dublin Republic of Ireland.

Abstract

Here we describe three cases of sarcoidosis which were diagnosed following COVID infection. Treating clinicians should consider post-COVID-19 sarcoidosis in their differential, as it represents a potentially treatable cause of persistent symptomatology.

Keywords: COVID‐19; sarcoidosis.

Publication types

Case Reports